Kati (Shanghai) Biotechnology Co., Ltd.

Kati (Shanghai) Biotechnology Co., Ltd. is a high-tech enterprise based on medical big data and intelligent cell fusion medicine, focusing on precision cell therapy and its industrialization, committed to providing disease prevention and treatment management services for elite groups. The core team is composed of experts from domestic and international universities, renowned clinical physicians, and personnel with rich corporate management experience. In January 2018, it was awarded titles by the medical industry such as "The Most Influential Precision Medicine Leader Enterprise Award," "The Most Popular Precision Medicine Enterprise Award," and "Member of the Asia-Pacific Precision Medicine Industry Alliance." The company always adheres to the mission of "Let everyone have a healthy future," upholds the philosophy that "medical innovation originates from genetic engineering and cell therapy," closely cooperates with relevant American institutions and laboratories to jointly conduct clinical research on cell therapy, focuses on the technical development of stem cell therapy and immune cell therapy, deeply studies clinical application technologies of cells, transforms the latest scientific and technological achievements into clinical applications, and constructs a comprehensive disease prevention and treatment management service system from precise prevention to precise treatment, covering health, sub-health, sub-disease, and disease, fulfilling its solemn commitment to society with rigorous scientific attitude and professional medical services.